sulforaphane has been researched along with Diabetic Retinopathy in 3 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Lv, J | 1 |
Bao, S | 1 |
Liu, T | 1 |
Wei, L | 1 |
Wang, D | 1 |
Ye, W | 1 |
Wang, N | 1 |
Song, S | 1 |
Li, J | 1 |
Chudhary, M | 1 |
Ren, X | 1 |
Kong, L | 1 |
Li, S | 1 |
Yang, H | 1 |
Chen, X | 1 |
Maeda, S | 1 |
Matsui, T | 1 |
Ojima, A | 1 |
Takeuchi, M | 1 |
Yamagishi, S | 1 |
3 other studies available for sulforaphane and Diabetic Retinopathy
Article | Year |
---|---|
Sulforaphane delays diabetes-induced retinal photoreceptor cell degeneration.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Endoplasmic | 2020 |
Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation.
Topics: Animals; Diabetic Retinopathy; Ependymoglial Cells; Glucose; Inflammasomes; Isothiocyanates; Male; N | 2019 |
Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Topics: Animals; Apoptosis; Brassicaceae; Cattle; Cells, Cultured; Chemokine CCL2; Diabetic Retinopathy; DNA | 2014 |